Kinnate Biopharma Inc (KNTE) Return on Assets ROA from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Kinnate Biopharma Inc   (NASDAQ: KNTE)


Kinnate Biopharma Inc 's ROA from the fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Kinnate Biopharma Inc 's ROA in the fourth quarter of 2023?
Kinnate Biopharma Inc recorded a cumulative net loss of $-113 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on assets (ROA) of -54.95%.

However, within the Healthcare sector 747 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from 4539 to 5085.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Total Assets Change -37.24 % -36.84 % -32.9 % -30.28 % -24.75 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -113 -127 -127 -122 -116
Return On Assets (TTM) -54.95 % -55.12 % -49.22 % -42.95 % -37.39 %
KNTE's Total Ranking # 5085 # 4539 # 4573 # 4593 # 5165
Total Assets (TTM) in million 173 190 216 241 276
Seq. Total Assets Change -8.6 % -12.19 % -10.57 % -12.56 % -8.01 %
Seq. Net Income Change - - - - -

KNTE's 5 Years Annual ROA >> Back to KNTE Management Effectiveness >> Compare KNTE ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 334
Sector # 748
Overall # 4973

Return On Assets Statistics
High Average Low
-23.25 %
-38.89 %
-54.72 %
(Dec 31 2021)   (Sep 30 2023)





Financial Statements
Kinnate Biopharma Inc 's Assets $ 173 million KNTE's Balance sheet
Kinnate Biopharma Inc 's Income $ -17 million Quarterly KNTE's Income Statement
KNTE's Income by Division See KNTE's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
FY
FY
Y / Y Total Assets Change -37.24 % -24.75 % - - -
Total Assets in million 173 276 367 0 0
Y / Y Net Income Change - - - - -
Net Income in million -113 -116 -90 0 0
Annual Return On Assets -65.03 % -42.12 % -24.47 % - -

KNTE's 5 Years Annual ROA >> Back to KNTE Management Effectiveness >> Compare KNTE ROA to its Competitors



More Return On Assets Ratios
KNTE's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
KNTE's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for KNTE's Competitors
Subscribers only: Roa for Kinnate Biopharma Inc 's Suppliers
Subscribers only: Return On Assets for KNTE's Customers

You may also want to know
KNTE's Roi KNTE's Inventory Turnover Ratio KNTE's Growth Rates KNTE's Dividend Comparisons
KNTE's Profitability Ratios KNTE's Asset Turnover Ratio KNTE's Dividend Growth
KNTE's Roe KNTE's Valuation Ratios KNTE's Financial Strength Ratios KNTE's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2023, within Healthcare Sector ROA

Date modified: 2026-08-31T01:01:25+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.